NM_001492.6:c.925T>C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001492.6(GDF1):​c.925T>C​(p.Ser309Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,461,894 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S309F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00011 ( 2 hom. )

Consequence

GDF1
NM_001492.6 missense

Scores

3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.728

Publications

2 publications found
Variant links:
Genes affected
GDF1 (HGNC:4214): (growth differentiation factor 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. The encoded protein is translated from a bicistronic mRNA that also encodes ceramide synthase 1. Mutations in this gene are associated with several congenital cardiovascular malformations. [provided by RefSeq, Jul 2016]
CERS1 (HGNC:14253): (ceramide synthase 1) This gene encodes a ceramide synthase enzyme, which catalyzes the synthesis of ceramide, the hydrophobic moiety of sphingolipids. The encoded enzyme synthesizes 18-carbon (C18) ceramide in brain neurons. Elevated expression of this gene may be associated with increased longevity, while decreased expression of this gene may be associated with myoclonus epilepsy with dementia in human patients. This protein is transcribed from a monocistronic mRNA as well as a bicistronic mRNA, which also encodes growth differentiation factor 1. [provided by RefSeq, Jul 2016]
CERS1 Gene-Disease associations (from GenCC):
  • progressive myoclonic epilepsy type 8
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.035881877).
BP6
Variant 19-18868791-A-G is Benign according to our data. Variant chr19-18868791-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 220404.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001492.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GDF1
NM_001492.6
MANE Select
c.925T>Cp.Ser309Pro
missense
Exon 8 of 8NP_001483.3
CERS1
NM_021267.5
MANE Select
c.*1194T>C
3_prime_UTR
Exon 8 of 8NP_067090.1
GDF1
NM_001387438.1
c.925T>Cp.Ser309Pro
missense
Exon 5 of 5NP_001374367.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GDF1
ENST00000247005.8
TSL:1 MANE Select
c.925T>Cp.Ser309Pro
missense
Exon 8 of 8ENSP00000247005.5
CERS1
ENST00000623882.4
TSL:1 MANE Select
c.*1194T>C
3_prime_UTR
Exon 8 of 8ENSP00000485308.1

Frequencies

GnomAD3 genomes
AF:
0.000127
AC:
19
AN:
149084
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00113
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000975
GnomAD2 exomes
AF:
0.00106
AC:
118
AN:
111764
AF XY:
0.000603
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00566
Gnomad ASJ exome
AF:
0.000137
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000315
GnomAD4 exome
AF:
0.000112
AC:
147
AN:
1312702
Hom.:
2
Cov.:
31
AF XY:
0.0000849
AC XY:
55
AN XY:
647564
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25780
American (AMR)
AF:
0.00464
AC:
142
AN:
30582
Ashkenazi Jewish (ASJ)
AF:
0.0000463
AC:
1
AN:
21602
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26752
South Asian (SAS)
AF:
0.00
AC:
0
AN:
75530
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44946
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4534
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1030594
Other (OTH)
AF:
0.0000764
AC:
4
AN:
52382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.419
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000127
AC:
19
AN:
149192
Hom.:
0
Cov.:
33
AF XY:
0.0000686
AC XY:
5
AN XY:
72852
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41182
American (AMR)
AF:
0.00113
AC:
17
AN:
15048
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3418
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5128
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9436
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66882
Other (OTH)
AF:
0.000964
AC:
2
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000131
Hom.:
0
Bravo
AF:
0.000298

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not provided (2)
-
1
-
GDF1-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
6.1
DANN
Benign
0.46
DEOGEN2
Uncertain
0.54
D
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.29
T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.036
T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
-0.46
N
PhyloP100
0.73
PROVEAN
Benign
-2.0
N
REVEL
Uncertain
0.53
Sift
Benign
0.25
T
Sift4G
Benign
0.31
T
Vest4
0.65
MutPred
0.80
Loss of catalytic residue at S309 (P = 0.0214)
MVP
0.47
MPC
1.2
ClinPred
0.021
T
GERP RS
0.87
Varity_R
0.18
gMVP
0.68
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs864622513; hg19: chr19-18979600; API